** Neoleukin Therapeutics' shares fall 1.3% to 69 cents premarket
** Co says it will initiate a reverse stock split of its common stock at a ratio of 1-for-5
** Stock split will be effective from Sept. 25
** Says stock split is part of NLTX's plan to regain compliance with Nasdaq's minimum bid price requirement
** Up to last close, shares up 37.3% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.